English French Notes Complete/Exclude 23. NUMBER OF TUMORS 24. DATE OF FIRST SYMPTOMS 25. DATE OF INITIAL DIAGNOSIS 26. DATE OF PATHOLOGIC DIAGNOSIS 27. PRIMARY SITE (ICD-O-2) 28. WHO HISTOLOGICAL CLASSIFICATION OF TUMOR 29. BEHAVIOR CODE (ICD-O-2) 31. DIAGNOSTIC CONFIRMATION 32. MOLECULAR MARKERS 33. TUMOR SIZE 34. TUMOR SIZE (SOURCE 35. KARNOFSKY'S RATING PRIOR TO THERAPY 34. TUMOR SIZE (SOURCE) 17. CLASS OF CASE.................: 1222 CHANGE IN SENSE OF SMELL AND/ OR TASTE.................... 1223 ALTERED ALERTNESS............ 1225 SPEECH DISTURBANCE........... 1226 PERSONALITY CHANGES.......... 1228 MEMORY LOSS.................. 1229 LACK OF CONCENTRATION........ 1230 DOUBLE VISION................ 1231 OTHER VISUAL DISTURBANCE..... 1232 DECREASED HEARING............ 1236 WEAKNESS OR PARALYSIS........ 1237 DIFFICULTY IN COORDINATION/ BALANCE..................... 1238 GENERALIZED SEIZURE.......... 1239 FOOD SEIZURE................. 1240 BLADDER INCONTINENCE......... 1241 BOWEL INCONTINENCE........... 1242 PAIN (OTHER THAN HEADACHE)... 1243 WEIGHT CHANGE................ 19. NEUROLOGICAL FINDINGS: 1248 MEMORY OR JUDGEMENT.......... 1249 VISUAL ACUITY................ 1250 VISUAL FIELDS................ 1251 EYE MOVEMENTS (EOM).......... 1252 FACIAL SENSATION............. 1253 FACIAL MOVEMENT.............. 1255 GAG REFLEX................... 1256 STERNOCLEIDOMASTOID/SHOULDER SHRUG STRENGTH.............. 1257 ARTICULATION OR ENUNCIATION.. 1259 TONGUE FASCICULATIONS OR ATROPHY..................... 1260 DECREASE IN SENSATION OF ANY SITE........................ 1261 CORTICAL SENSORY DEFICIT..... 1262 WEAKNESS, ATROPHY OR FASCICULATION OF ANY SITE................. 1263 ATAXIA OF GAIT............... 1264 TRUNCAL ATAXIA............... 1266 RAPID ALTERNATING MOVEMENTS.. 1267 FINGER TO FINGER NOSE TESTING 1268 HEEL TO KNEE TO SHIN TESTING. 1269 DEEP TENDON REFLEXES IN UPPER EXTREMITIES................. 1270 DEEP TENDON REFLEXES IN LOWER EXTREMITIES................. 1271 BABINSKI SIGN................ 1272 HOFFMAN REFLEX............... 1273 OTHER ABNORMAL REFLEXES...... 20. PRE-THERAPY DIAGNOSTIC STUDIES: 1275 CT SCAN OF BRAIN............. 1276 CT SCAN OF SPINE............. 1278 ISOTOPE BRAIN SCAN........... 1279 PET SCAN..................... 1280 SPECT SCAN................... 1281 MRI OF BRAIN................. 1282 MRI OF SPINE................. 1283 FUNCTIONAL MRI............... 21. TUMOR LOCATION/INVOLVEMENT: 1286 FRONTAL LOBE................. 1287 TEMPORAL LOBE................ 1288 PARIETAL LOBE................ 1289 OCCIPITAL LOBE............... 1290 OPTIC NERVES................. 1291 PITUITARY GLAND.............. 1292 PINEAL GLAND................. 1294 BRAIN STEM................... 1295 SKULL BASE................... 1296 OTHER SKULL.................. 1297 SPINAL CORD.................. 1298 CEREBRAL SPINAL FLUID (CSF).. 1299 CRANIAL MENINGES............. 1300 SPINAL MENINGES.............. 1305 23. NUMBER OF TUMORS.............. 1306 24. DATE OF FIRST SYMPTOMS........ 25. DATE OF INITIAL DIAGNOSIS.....: 1307 26. DATE OF PATHOLOGIC DIAGNOSIS.. 27. PRIMARY SITE (ICD-O-2)........: 1308 28. WHO HISTOLOGICAL CLASSIFICATION OF TUMOR..................... 29. BEHAVIOR CODE (ICD-O-2).......: 31. DIAGNOSTIC CONFIRMAITON.......: 1309 32. MOLECULAR MARKERS............. 1394 33. TUMOR SIZE.................... 34. TUMOR SIZE (SOURCE)...........: Size not recorded 1310 34. TUMOR SIZE (SOURCE)........... 1311 35. KARNOFSKY'S RATING PRIOR TO THERAPY...................... 36. PROTOCOL PARTICIPATION 37. PROTOCOL PHASE 38. DATE OF FIRST COURSE TREATMENT 39. DATE OF INPATIENT ADMISSION 40. DATE OF INPATIENT DISCHARGE 41. DATE OF NON CA-DIRECTED SURGERY 42. DIAGNOSTIC/EVALUATIVE/PALLIATIVE (NON CA-DIRECTED) SURGERY 43. DATE OF CA-DIRECTED SURGERY 44. SURGICAL APPROACH 45. EXTENT OF SURGICAL RESECTION 46. SIZE OF RESIDUAL PRIMARY TUMOR FOLLOWING CA-DIRECTED SURGERY 47. SIZE OF RESIDUAL PRIMARY TUMOR FOLLOWING CA-DIRECTED SURGERY (SOURCE) 48. SURGICAL COMPLICATIONS/POST SURGICAL EVENTS 49. REASON FOR NO SURGERY 50. RADIATION THERAPY 51. DATE RADIATION STARTED 52. DATE RADIATION ENDED 53. TOTAL RADIATION DOSE (cGy) 54. NUMBER OF TREATMENTS TO THIS VOLUME 55. TYPE OF EXTERNAL BEAM RADIATION 56. INTERSTITIAL RADIATION/BRACHYTHERAPY 57. STEREOTACTIC RADIOSURGERY 58. RADIATION/SURGERY SEQUENCE 59. RADIATION COMPLICATIONS 60. REASON FOR NO RADIATION 61. DATE CHEMOTHERAPY STARTED 63. TYPE OF CHEMOTHERAPEUTIC AGENTS ADMINISTERED 64. CHEMOTHERAPEUTIC ROUTE 65. CHEMOTHERAPY COMPLICATIONS 66. REASON FOR NO CHEMOTHERAPY 67. DATE OTHER TREATMENT STARTED 68. OTHER TREATMENT 69. KARNOFSKY'S RATING AT TIME OF DISCHARGE/TRANSFER 1312 36. PROTOCOL PARTICIPATION........ 37. PROTOCOL PHASE................: Not on 1313 37. PROTOCOL PHASE................ 38. DATE OF FIRST COURSE TREATMENT: 1 39. DATE OF INPATIENT ADMISSION... 1.1 40. DATE OF INPATIENT DISCHARGE... 41. DATE OF NON CA-DIR SURGERY...: 42. DIAGNOSTIC/EVALUATIVE/PALLIATIVE (NON CA-DIRECTED) SURGERY: NONE, NO NON CA-DIRECTED SURGICAL PROCEDURE...: Yes VENTRICULOSTOMY, OR EXTERNAL VENTRICULAR DRAIN: No CSF SHUNT, VENTRICULOPERITONEAL...............: No CSF SHUNT, THIRD VENTRICULOSTOMY..............: No CSF SHUNT, OTHER..............................: No STEREOTACTIC BIOPSY...........................: No OPEN BRAIN BIOPSY.............................: No OPEN BIOPSY OF SPINAL CORD TUMOR..............: No LAMINECTOMY FOR SPINAL CORD TUMOR, W/O TUMOR RESECTION, W/O OPENING DURA........: No UNKNOWN IF SURGERY DONE.......................: No NONE, NO NON CA-DIRECTED SURGICAL PROCEDURE..........: No 1314 NONE, NO NON CA-DIRECTED SURGICAL PROCEDURE.......... 1315 VENTRICULOSTOMY, OR EXTERNAL VENTRICULAR DRAIN........... 1316 CSF SHUNT, VENTRICULOPERITONEAL........ 1317 CSF SHUNT, THIRD VENTRICULOSTOMY....... 1318 CSF SHUNT, OTHER....................... 1319 STEREOTACTIC BIOPSY.......... 1320 OPEN BRAIN BIOPSY............ 1321 OPEN BIOPSY OF SPINAL CORD TUMOR....................... 1322 LAMINECTOMY FOR SPINAL CORD TUMOR, W/O TUMOR RESECTION, W/O OPENING DURA........... 1323 LAMINECTOMY FOR SPINAL CORD TUMOR, W/O TUMOR RESECTION, W OPENING DURA............. 1325 UNKNOWN IF SURGERY DONE...... 43. DATE OF CA-DIRECTED SURGERY...: 44. SURGICAL APPROACH.............: None, no ca-directed surgery 45. EXTENT OF SURGICAL RESECTION..: None, no surgery performed 46. SIZE OF RESIDUAL PRIMARY TUMOR AFTER CA-DIR SURGERY.........: NA, surgical treatment not administered 47. SIZE OF RESIDUAL PRIMARY TUMOR AFTER CA-DIR SURGERY (SOURCE): Size not recorded 48. SURGICAL COMPLICATIONS/POST SURGICAL EVENTS: ANESTHETIC PROBLEM...........: NA, surgery not performed HEMORRHAGE AT OPERATIVE SITE.: NA, surgery not performed SEIZURE......................: NA, surgery not performed INFECTION(S).................: NA, surgery not performed DVT (DEEP VENOUS THROMBOSIS..: NA, surgery not performed PERSISTENT NEUROLOGICAL WORSENING OVER 4 DAYS POST-OP.........: NA, surgery not performed OTHER........................: NA, surgery not performed 44. SURGICAL APPROACH.............: Surgical approach unknown 45. EXTENT OF SURGICAL RESECTION..: Unknown if surgery performed ANESTHETIC PROBLEM...........: Unknown HEMORRHAGE AT OPERATIVE SITE.: Unknown DVT (DEEP VENOUS THROMBOSIS..: Unknown 1326 44. SURGICAL APPROACH............. 1327 45. EXTENT OF SURGICAL RESECTION.. 1328 46. SIZE OF RESIDUAL PRIMARY TUMOR AFTER CA-DIR SURGERY......... 1329 47. SIZE OF RESIDUAL PRIMARY TUMOR AFTER CA-DIR SURGERY (SOURCE) 1330 ANESTHETIC PROBLEM........... 1331 HEMORRHAGE AT OPERATIVE SITE. 1334 DVT (DEEP VENOUS THROMBOSIS). 1335 PERSISTENT NEUROLOGICAL WORSENING OVER 4 DAYS POST-OP......... 58 49. REASON FOR NO SURGERY......... 50. RADIATION THERAPY.............: None 51. DATE RADIATION STARTED........: 52. DATE RADIATION ENDED..........: 00/00/0000 53. TOTAL RADIATION DOSE (cGy)....: No radiation administered 54. NUMBER OF TREATMENTS TO THIS VOLUME.......................: 55. TYPE OF EXT BEAM RADIATION....: No radiation therapy 56. INTERSTITIAL RAD/BRACHYTHERAPY: None, brachytherapy not given 57. STEREOTACTIC RADIOSURGERY.....: None, not administered 58. RADIATION/SURGERY SEQUENCE....: 59. RADIATION COMPLICATIONS: SKIN REACTIONS...............: NA, radiation tx not administered ANOREXIA.....................: NA, radiation tx not administered NAUSEA OR VOMITING...........: NA, radiation tx not administered FATIGUE......................: NA, radiation tx not administered NEUROLOGIC WORSENING.........: NA, radiation tx not administered 50. RADIATION THERAPY.............: Unk, death cert cases only 52. DATE RADIATION ENDED..........: 99/99/9999 53. TOTAL RADIATION DOSE (cGy)....: Dose unknown 55. TYPE OF EXT BEAM RADIATION....: Unknown 56. INTERSTITIAL RAD/BRACHYTHERAPY: Unknown 57. STEREOTACTIC RADIOSURGERY.....: Unknown SKIN REACTIONS...............: Unknown NAUSEA OR VOMITING...........: Unknown NEUROLOGIC WORSENING.........: Unknown 1345 50. RADIATION THERAPY............. 361 52. DATE RADIATION ENDED.......... 1336 53. TOTAL RADIATION DOSE (cGy).... 56 54. NUMBER OF TREATMENTS TO THIS VOLUME...................... 1337 55. TYPE OF EXT BEAM RADIATION.... 1338 56. INTERSTITIAL RAD/BRACHYTHERAPY 1339 57. STEREOTACTIC RADIOSURGERY..... 51.3 58. RADIATION/SURGERY SEQUENCE.... 1340 SKIN REACTIONS............... 1342 NAUSEA OR VOMITING........... 1344 NEUROLOGIC WORSENING......... 75 60. REASON FOR NO RADIATION....... 61. DATE CHEMOTHERAPY STARTED.....: 63. TYPE OF CHEMOTHERAPEUTIC AGENTS ADMINISTERED: PROCARBAZINE.................: NA, chemotherapy not administered CCNU.........................: NA, chemotherapy not administered VINCRISTINE..................: NA, chemotherapy not administered HYDROXYUREA..................: NA, chemotherapy not administered METHOTREXATE.................: NA, chemotherapy not administered CISPLATIN....................: NA, chemotherapy not administered BCNU.........................: NA, chemotherapy not administered BCNU WAFER IMPLANT...........: NA, chemotherapy not administered VP-16........................: NA, chemotherapy not administered CARBOPLATIN..................: NA, chemotherapy not administered TEMOZOLOMIDE.................: NA, chemotherapy not administered CYCLOPHOSPHAMIDE.............: NA, chemotherapy not administered CPT-11.......................: NA, chemotherapy not administered TAMOXIFEN....................: NA, chemotherapy not administered INTERFERON...................: NA, chemotherapy not administered CYTARABINE (ARA-C)...........: NA, chemotherapy not administered OTHER........................: NA, chemotherapy not administered BCNU WAFER IMPLANT...........: Unknown 1351 BCNU WAFER IMPLANT........... 64. CHEMOTHERAPEUTIC ROUTE........: NA, chemotherapy not administered 64. CHEMOTHERAPEUTIC ROUTE........: Unknown 1358 64. CHEMOTHERAPEUTIC ROUTE........ 65. CHEMOTHERAPY COMPLICATIONS: HEARING LOSS.................: NA, chemotherapy not administered INFECTION....................: NA, chemotherapy not administered NAUSEA AND VOMITING REQUIRING CESSATION OF CHEMOTHERAPY....: NA, chemotherapy not administered PERIPHERAL BLOOD COUNT DROP/ BLEEDING/CESSATION OF CHEMO- THERAPY AND/OR TRANSFUSION.: NA, chemotherapy not administered PERIPHERAL NEUROPATHY........: NA, chemotherapy not administered RENAL FAILURE................: NA, chemotherapy not administered PULMONARY TOXICITY...........: NA, chemotherapy not administered HEARING LOSS.................: Unknown PERIPHERAL NEUROPATHY........: Unknown RENAL FAILURE................: Unknown PULMONARY TOXICITY...........: Unknown 1359 HEARING LOSS................. 1361 NAUSEA AND VOMITING REQUIRING CESSATION OF CHEMOTHERAPY... 1362 PERIPHERAL BLOOD COUNT DROP/ BLEEDING/CESSATION OF CHEMO- THERAPY AND/OR TRANSFUSION. 1363 PERIPHERAL NEUROPATHY........ 1364 RENAL FAILURE................ 1365 PULMONARY TOXICITY........... 76 66. REASON FOR NO CHEMOTHERAPY.... 67. DATE OTHER TREATMENT STARTED..: 68. OTHER TREATMENT...............: 1367 69. KARNOFSKY'S RATING AT TIME OF DISCHARGE/TRANSFER........... 70. DATE OF FIRST RECURRENCE 71. TYPE OF FIRST RECURRENCE 72. DATE OF PROGRESSION 73. TYPE OF PROGRESSION 74. RECURRENCE/PROGRESSION DOCUMENTATION 75. KARNOFSKY'S RATING AT TIME OF RECURRENCE/PROGRESSION 70. TYPE OF FIRST RECURRENCE 71. DATE OF FIRST RECURRENCE 70 70. DATE OF FIRST RECURRENCE...... 1372 71. TYPE OF FIRST RECURRENCE...... 1368 72. DATE OF PROGRESSION........... 1369 73. TYPE OF PROGRESSION........... 74. RECURRENCE/PROGRESSION DOCUMENTATION................: No recurrence/progession 1370 74. RECURRENCE/PROGRESSION DOCUMENTATION................ 75. KARNOFSKY'S RATING AT TIME OF RECURRENCE/PROGRESSION.......: 888 1371 75. KARNOFSKY'S RATING AT TIME OF RECURRENCE/PROGRESSION....... 76. DATE OF SUBSEQUENT TREATMENT FOR RECURRENCE/PROGRESSION 77. PROTOCOL PARTICIPATION (SUBSEQUENT TREATMENT) 78. TYPE OF SUBSEQUENT SURGICAL TREATMENT FOR RECURRENCE/PROGRESSION 79. TYPE OF SUBSEQUENT RADIATION TREATMENT FOR RECURRENCE/PROGRESSION 80. TYPE OF SUBSEQUENT CHEMOTHERAPY FOR RECURRENCE/PROGRESSION 81. OTHER TYPE OF SUBSEQUENT TREATMENT FOR RECURRENCE/PROGRESSION SUBSEQUENT TREATMENT 76. DATE OF SUBSEQUENT TREATMENT FOR RECURRENCE/PROGRESSION...: 77. PROTOCOL PARTICIPATION (SUBSEQUENT TREATMENT).......: Not on 1373 77. PROTOCOL PARTICIPATION (SUBSEQUENT TREATMENT)....... 78. TYPE OF SUBSEQUENT SURGICAL TX FOR RECURRENCE/PROGRESSION...: None, no subsequent surgery 1374 78. TYPE OF SUBSEQUENT SURGICAL TX FOR RECURRENCE/PROGRESSION... 79. TYPE OF SUBSEQUENT RADIATION TX FOR RECURRENCE/PROGRESSION...: None 1375 79. TYPE OF SUBSEQUENT RADIAITON TX FOR RECURRENCE/PROGRESSION... 80. TYPE OF SUBSEQUENT CHEMOTHERAPY FOR RECURRENCE/PROGRESSION: Chemotherapy not administered PROCARBAZINE.......: NA CARBOPLATIN........: NA CCNU...............: NA TEMOZOLOMIDE.......: NA VINCRISTINE........: NA CYCLOPHOSPHAMIDE...: NA HYDROXYUREA........: NA CPT-11.............: NA METHOTREXATE.......: NA TAMOXIFEN..........: NA #################### #################### #################### #################### #################### #################### #################### #################### #################### #################### #################### #################### #################### #################### ####################